Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse

Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse

Herein, we aimed to report a diffuse large B cell lymphoma (DLBCL) case that had extensive cutaneous relapse with no skin involvement previously. A 59-year-old man presented to hospital in April 2014 with fatigue, anorexia, fever, and anemia. Cervical lymph node biopsy revealed CD20+, BCL2+, MUM1+,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Umit Yavuz Malkan, Gursel Gunes, Okan Yayar, Haluk Demiroglu
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Case Reports in Medicine
Online Access:	http://dx.doi.org/10.1155/2015/137682
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diffuse Large B Cell Lymphoma with Cutaneous and Gastrointestinal Involvement
by: Aye-Mya-Mya Kyaw, et al.
Published: (2022-01-01)

Primary diffuse cutaneous large B-cell lymphoma, anaplastic type
by: S. V. Antonyuk, et al.
Published: (2012-04-01)

A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma
by: Mary Awad, et al.
Published: (2020-01-01)

Mutation profile of diffuse large B-cell lymphoma with relapses in the central nervous system
by: E. N. Voropaeva, et al.
Published: (2022-10-01)

Transformation of a Cutaneous Follicle Center Lymphoma to a Diffuse Large B-Cell Lymphoma—An Unusual Presentation
by: J. Dias Coelho, et al.
Published: (2010-01-01)

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01)

Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies
by: Allison M. Bock, et al.
Published: (2025-07-01)

Concomitant group A Streptococcus and disseminated mpox infection mimicking relapsed diffuse large B-cell lymphoma
by: Viviane Liao, BA, et al.
Published: (2025-07-01)

Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia
by: Ya Hwee Tan, et al.
Published: (2025-02-01)

Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
by: Narendranath Epperla, et al.
Published: (2024-11-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)

Lenalidomide in Diffuse Large B-Cell Lymphomas
by: Annalisa Chiappella, et al.
Published: (2012-01-01)

Lenalidomide in Diffuse Large B-Cell Lymphoma
by: Catherine Thieblemont, et al.
Published: (2012-01-01)

Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
by: Irene Dogliotti, et al.
Published: (2024-07-01)

Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report
by: Satoshi Mitsuyuki, et al.
Published: (2025-04-01)

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT
by: Ulrike Bacher, et al.
Published: (2023-04-01)

Personalized medicine in diffuse large B-cell lymphoma
by: Prashant Mehta, et al.
Published: (2019-01-01)

Diffuse large B-cell lymphoma misdiagnosed as cellulitis
by: Tamotsu Kuribayashi, et al.
Published: (2025-04-01)

Renal Involvement in Diffuse Large B-cell Lymphoma
by: Shashikant Saini, et al.
Published: (2024-10-01)

Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma—importance of pre-CAR-T optimization
by: Phoebe Joy Ho, et al.
Published: (2025-08-01)

Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting
by: Niamh Carey, et al.
Published: (2023-12-01)

The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review
by: Andrea Emanuele Guerini MD, et al.
Published: (2025-06-01)

Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
by: Shin Nagai, et al.
Published: (2018-01-01)

Cutaneous Metastasis in Patient With Relapse Case of Primary Testicular Lymphoma
by: Mahesh Mathur, et al.
Published: (2025-08-01)

Non-diffuse Large B-cell Lymphoma. Case Presentation
by: Miguel Ángel Serra Valdés, et al.
Published: (2019-09-01)

Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma
by: Maria Cristina Pirosa, et al.
Published: (2024-12-01)

Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma
by: Janek S. Walker, et al.
Published: (2025-07-01)

Survival of HIV associated diffuse large B-cell lymphoma and Burkitt lymphoma in China
by: Yu Xiong, et al.
Published: (2024-12-01)

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis
by: Danqing Kong, et al.
Published: (2024-12-01)

Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas
by: Josie G. Ford, et al.
Published: (2025-08-01)

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (DLBCL NOS) Presenting as Multiple Subcutaneous Nodules: An Unusual Cutaneous Presentation of Systemic Disease
by: Nika Tavberidze, et al.
Published: (2023-01-01)

Prognostic significance of AIF expression in diffuse large B-cell lymphoma
by: Vitaly A. Rosin, et al.
Published: (2025-01-01)

Does CBD induce apoptosis in diffuse large B cell lymphoma?
by: Xu, S.
Published: (2018-08-01)

Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
by: Alexandra Ioana Cioroianu, et al.
Published: (2019-01-01)

A CASE OF DIFFUSE LARGE B CELL LYMPHOMA PRESENTING AS OSTEOSARCOMA
by: Mine Ezgi Payaslı, et al.
Published: (2024-12-01)

CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy
by: Hui Luo, et al.
Published: (2025-05-01)

Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
by: Narendranath Epperla, et al.
Published: (2025-01-01)

A CASE WITH COMPLICATED DIAGNOSIS FOR DIFFUSE B-CELL LARGE CELL LYMPHOMA
by: E. I. Zyablova, et al.
Published: (2019-02-01)

Successful treatment of synchronous hairy cell leukaemia and diffuse large B cell lymphoma in a patient with severe hypercalcemia and extensive osteolytic lesions
by: Marković Olivera, et al.
Published: (2022-01-01)

Analysis of microsatellite aberrations and loss of heterozygosity in follicular lymphoma, diffuse large B-cell lymphoma, and high-grade B-cell lymphoma patients
by: K. A. Sychevskaya, et al.
Published: (2022-04-01)